Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02023372 · ClinicalTrials.gov registry record · NA
Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine
A NA study of Spondylolisthesis and Spinal Stenosis, sponsored by NuTech Medical.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT02023372: Completed NA study of Spondylolisthesis and Spinal Stenosis, sponsored by NuTech Medical.
NCT02023372 is a NA study of Spondylolisthesis and Spinal Stenosis that has completed, run by NuTech Medical. The registered enrollment target is 57 participants, below the 150-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02023372, a NA study of Spondylolisthesis and Spinal Stenosis, has completed, sponsored by NuTech Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether NuCel is effective in promoting spinal fusion in degenerative disease of the lumbar spine.
Primary Outcome
CT scan will be used to evaluate fusion of one, two, or three levels
Conditions Studied
Interventions
- OTHER NuCel with Autograft
Study Locations (1)
North Carolina
- Carolina NeuroSurgery and Spine - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-08-16 |
| Phase | NA |
What the finished NCT02023372 record still lists
NCT02023372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 150-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (62% lower).
The record links to 5 conditions, with Spondylolisthesis appearing as the primary indexed condition, and to 1 intervention - of which NuCel with Autograft is the first listed.
NCT02023372 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02023372 about?
NCT02023372 is a clinical study titled "Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine". The purpose of this study is to determine whether NuCel is effective in promoting spinal fusion in degenerative disease of the lumbar spine.
What is the current status of trial NCT02023372?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2013-12. Estimated completion is 2019-08-16.
What conditions does trial NCT02023372 study?
This clinical trial studies the following conditions: Spondylolisthesis, Spinal Stenosis, Spondylosis, Intervertebral Disc Degeneration, Intervertebral Disc Disease.
What interventions are being tested in trial NCT02023372?
The interventions under investigation include: NuCel with Autograft (OTHER).
Who is sponsoring clinical trial NCT02023372?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02023372 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spondylolisthesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02023372's enrollment target sits among peer trials
57 12th of 18 higher than 7 of 18 other Spondylolisthesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spondylolisthesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PREventing Pain After Surgery
RECRUITING · NA
-
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
RECRUITING · NA
-
Studying Melatonin and Recovery in Teens
RECRUITING · NA
-
Lumbar Fusion With Porous Versus Non-Porous Cages
ACTIVE NOT RECRUITING · NA
-
Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages
ACTIVE NOT RECRUITING · NA
-
Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia